AstraZeneca made a $10 billion offer for Rhythm Pharmaceuticals, WSJ reports
The reported bid would be a sizable bolt-on for AstraZeneca's rare disease and obesity pipeline and follows a wave of large pharma M&A.
Read at WSJ →Full coverage · 14 outlets
- WSJ · lead
- ReutersAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
- U.S. NewsAstraZeneca Made $10 Billion Offer for Obesity Drugmaker Rhythm, Sources Say
- www.marketscreener.comAstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reports
- Yahoo Finance SingaporeAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports
- investingLiveAstraZeneca makes $10 billion offer for obesity drugmaker Rhythm, WSJ reports
- KELO-AMAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports
- SRN NewsAstraZeneca made $10 billion bid for Rhythm Pharmaceuticals, WSJ reports
- TradingViewRhythm Pharmaceuticals jumps on report AstraZeneca made $10B bid
- شبكة تواصل الإخباريةAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say
- Investing.comAstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say By Reuters
- FinimizeAstraZeneca Weighs A $10 Billion Bid For Rhythm Pharma
- Yahoo FinanceRYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid Report
- MSNAstraZeneca made $10 billion bid for obesity drugmaker Rhythm, WSJ reports